ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine - The Cardiology Advisor

ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine - The Cardiology Advisor: A report presented at AHA 2021 finds that the PULS 5-year risk score for new ACS increases from 11% to 25% after mRNA COVID-19 vaccination.